Neos Therapeutics Inc (NEOS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2940 N. HIGHWAY 360 GRAND PRAIRIE, TX 75050

Neos Therapeutics, Inc. operates as a drug delivery and contract manufacturing company. The Company researches, develops, manufactures, and commercializes prescription, over-the-counter, and veterinary products. Neos Therapeutics markets its products worldwide.

Data as of 2021-04-03 12:02:28 -0400
Market Cap0 Shares Outstanding49.757 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS-0.439
Price/Sales Debt to Equity-3.14 EBITDA-9.404 Million
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash12.744 Million Current Debt67.161 Million Gross Profit32.425 Million
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date2021-03-22 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NEOS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NEOS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NEOS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EISENSTADT RICHARD I CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2021-03-19 2

ROBITAILLE GREGORY J

  • Director
No longer subject to file 2021-03-19 1

FONG BRYANT

  • Director
No longer subject to file 2021-03-19 1

SCHMID JOHN P.

  • Director
No longer subject to file 2021-03-19 1

HELLER ALAN L

  • Director
No longer subject to file 2021-03-19 1

HECHT BETH

  • Director
No longer subject to file 2021-03-19 1

SZYPER LINDA M

  • Director
No longer subject to file 2021-03-19 1

MCLAUGHLIN GERALD W. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2021-03-19 2

ROBINSON JAMES A. JR.

  • Director
No longer subject to file 2021-03-19 1

LIMONGELLI JOHN M SVP & GENERAL COUNSEL

  • Officer
No longer subject to file 2021-03-19 2

MCDONNELL THOMAS P CHIEF COMMERCIAL OFFICER

  • Officer
35,864 2018-05-01 0

GARG VIPIN K CHIEF EXECUTIVE OFFICER

  • Officer
160,748 2018-03-01 0

ENGELKING DOROTHY VP, REGULATORY AFFAIRS

  • Officer
10,416 2018-03-01 0

EDICK PAUL R

  • Director
0 2017-07-03 0

MARTENS JUERGEN CHIEF TECH/OPERATIONS OFFICER

  • Officer
25,000 2017-05-01 0

SCHULER JACK W

  • 10% Owner
2,338,671 2017-02-17 0

PRESIDIO PARTNERS 2007, L.P.

PRESIDIO PARTNERS 2007 (PARALLEL), L.P.

PRESIDIO PARTNERS 2007 GP, L.P.

COLLIER DAVID J

WATSON JAMES F

PRESIDIO PARTNERS 2007 GP, LLC

SOHAIL FAYSAL A.

  • 10% Owner
1,599,993 2016-04-18 0

TENGLER MARK CHIEF TECHNOLOGY OFFICER

  • Officer
0 2015-09-01 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-07-28 0

KEARNY VENTURE ASSOICATES II LLC

BURRILL LIFE SCIENES CAPITAL FUND III L P

CASTELEIN CALEY

DALAL ANUPAM

  • 10% Owner
No longer subject to file 2015-07-28 0

IANNELLI RALPH

ESSEX CAPITAL CORP

  • 10% Owner
No longer subject to file 2015-07-28 0

BLUHM ANDREW G

DELAWARE STREET CAPITAL MASTER FUND, L.P.

DSC ADVISORS, L.L.C.

DSC ADVISORS, L.P.

DSC MANAGERS, L.L.C.

DELAWARE STREET CAPITAL L P

  • 10% Owner
No longer subject to file 2015-07-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEOS THERAPEUTICS INC NEOS 2021-03-19 22:15:03 UTC -49.5722 49.6422 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 21:45:03 UTC -43.4657 43.5357 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 21:15:03 UTC -43.4657 43.5357 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 20:45:03 UTC -43.124 43.194 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 20:15:03 UTC -43.124 43.194 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 19:45:03 UTC -43.124 43.194 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 19:15:03 UTC -43.124 43.194 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 18:45:03 UTC -37.2566 37.3266 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 18:15:03 UTC -37.2566 37.3266 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 17:45:03 UTC -37.2566 37.3266 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 17:15:03 UTC -37.2566 37.3266 750000
NEOS THERAPEUTICS INC NEOS 2021-03-19 16:45:03 UTC -48.4169 48.4869 750000
NEOS THERAPEUTICS INC NEOS 2021-03-19 16:15:03 UTC -48.4169 48.4869 800000
NEOS THERAPEUTICS INC NEOS 2021-03-19 15:45:03 UTC -48.4169 48.4869 600000
NEOS THERAPEUTICS INC NEOS 2021-03-19 15:15:03 UTC -48.4169 48.4869 600000
NEOS THERAPEUTICS INC NEOS 2021-03-19 14:45:03 UTC -48.4169 48.4869 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 14:15:03 UTC -48.4169 48.4869 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 13:45:03 UTC -48.4169 48.4869 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 13:15:03 UTC -48.4169 48.4869 700000
NEOS THERAPEUTICS INC NEOS 2021-03-19 12:45:03 UTC -48.4169 48.4869 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments